Tag.bio is a biotechnology company that provides a cloud-based platform for analyzing and interpreting large-scale genomic data. The company's platform uses machine learning algorithms to identify patterns and relationships in genomic data, enabling researchers to gain insights into the underlying biology of diseases and develop new treatments. Tag.bio's platform is used by leading academic and commercial research institutions around the world, and the company has partnerships with major pharmaceutical companies to develop new drugs and therapies. Tag.bio was founded in 2018 and is headquartered in Palo Alto, California.